 Connection
William Robinson to Injections, Subcutaneous
This is a "connection" page, showing publications William Robinson has written about Injections, Subcutaneous.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.039 |
|
|
|
-
Lewis KD, Robinson WA, Millward MJ, Powell A, Price TJ, Thomson DB, Walpole ET, Haydon AM, Creese BR, Roberts KL, Zalcberg JR, Gonzalez R. A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma. Invest New Drugs. 2008 Feb; 26(1):89-94.
Score: 0.017
-
Ward HP, Vautrin R, Kurnick J, Robinson WA. Presence of a myeloproliferative factor in patients with polycythemia vera and agnogenic myeloid metaplasia. I. Expansion of the erythropoietin-responsive stem cell compartment. Proc Soc Exp Biol Med. 1974 Oct; 147(1):305-8.
Score: 0.007
-
Sanchez A, Robinson WA, Cohn A, Gonzalez R, Adlakha A. Low-dose alpha-interferon treatment of chronic myeloid leukemia. Am J Hematol. 1992 Jan; 39(1):61-2.
Score: 0.006
-
Gordon GS, Ambruso DR, Robinson WA, Githens JH. Intranasal administration of deferoxamine to iron overloaded patients. Am J Med Sci. 1989 May; 297(5):280-4.
Score: 0.005
-
Elenbaas RM, Frost GL, Robinson WA, Collier RE, McNabney WK, Ryan JL, Singsank MJ. Subcutaneous epinephrine vs. nebulized metaproterenol in acute asthma. Drug Intell Clin Pharm. 1985 Jul-Aug; 19(7-8):567-71.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|